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Introduction
Cancer cells often show abnormal cell cycle control in response
to external stimuli and this feature has attracted much scientific
interest. Many examples now exist in which signaling
pathways can induce the G1/S cell cycle transition. Fewer
examples exist whereby signaling pathways stop cells from
cycling and dividing. Studies on a natural variation of the
mitotic cycle, the endocycle, have helped to illuminate this
question (Edgar and Orr-Weaver, 2001). The endocycle (as
seen for example in cardiomyocytes, trophoblasts, and
Drosophila nurse and follicle cells) is a variation of the normal
cell cycle in which rounds of DNA replication and growth
occur without intervening mitoses (Zimmet and Ravid, 2000).
A critical characteristic of the endocycle is its capacity to
bypass the important controls that regulate normal transitions
in mitotic cycles. How this bypass is accomplished is largely
unknown; although some of the factors that control the
endocycle have been partially characterized (Edgar and Orr-
Weaver, 2001). Importantly, a comparative approach that
addresses this question might aid our understanding of how
cells become cancerous.
In normal mitotic cells cyclin-dependent kinases (Cdks)
induce phosphorylation events that control whether the cell
enters the M- or S-phase. CycA/Cdk1 and CycB/Cdk1
complexes that can be activated by Cdc25-type phosphatases
mediate M-phase control. S-phase is controlled by other
complexes: CycE/Cdk2, CycA/Cdk2, and CycD/Cdk4 or
Cdk6. Some of these complexes are known to be negatively
regulated by several Cdk inhibitors, such as p27Kip1. p27Kip1
inhibits CycE/Cdk2 complexes and thereby arrests cells in the
G1-phase (Olashaw and Pledger, 2002).
Cells normally progress through the cell cycle in a series of
sequential steps in which each step is dependent on the proper
completion of the previous stage. However, endocycling cells
are exceptions to this rule because they proceed to S-phase
without completing M-phase. How this occurs is not
understood. In some endocycling cells, bypassing the mitotic
stage correlates with eliminating or reducing the Cdk activity
required for M-phase entry. For example in Drosophila early
embryonic cells and follicle cells, components and regulators
of the M-phase can be eliminated at a transcriptional level
and/or at a posttranscriptional level (Deng et al., 2001; Sauer
et al., 1995; Sigrist and Lehner, 1997). Posttranscriptional
modulations are often mediated by ubiquitination via the APC-
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complex with degradation of the cyclins and securins (Peters,
2002; Vodermaier, 2001).
The key question in endocycle regulation is how the
transition from the mitotic phase to the endocycle is controlled.
Two signaling pathways have been identified as regulators of
the mitotic-to-endocycle transition: the thrombopoetin pathway,
which acts during differentiation of megakaryocytes and the
Notch pathway, which acts during Drosophila oogenesis and
during the differentiation of trophoblasts (Deng et al., 2001;
Lopez-Schier and St Johnston, 2001; Nakayama et al., 1997;
Wu et al., 2003; Zimmet and Ravid, 2000). Human
teratocarcinomas also seem to arise from defects in the mitotic-
to-endocycle transition in trophoblasts (Cross, 2000). The key
cell-cycle targets of these pathways, however, remain elusive.
In Drosophila follicle cells the function of the Notch pathway
in the mitotic-to-endocycle transition has been well established
(Deng et al., 2001; Lopez-Schier and St Johnston, 2001).
Specifically, the ligand Delta is secreted by germ line cells and
activates Notch in the follicle cells. Subsequently, the
cytoplasmic portion of Notch is cleaved by Presenillin and
moves to the nucleus where, in combination with a transcription
factor, Suppressor of Hairless [Su(H)], it affects the
transcription of various target genes. Lack of Notch activity in
Drosophila follicle cells leads to prolonged mitosis at the
expense of endocycles. This has led to the suggestion that Notch
functions in this context as a tumor suppressor (Deng et al.,
2001; Lopez-Schier and St Johnston, 2001). Because very few
signaling pathways have been identified that stop the mitotic
cell cycle, it is important to understand in detail the relationship
between the Notch pathway and known cell cycle regulators.
We have previously shown that one of the cell cycle
components that responds to Notch activity at the
transcriptional level, String/Cdc25 phosphatase, which is a
regulator of the transition between S- and M-phase, is not
sufficient, by itself, to keep all the cells in mitotic phase,
suggesting that other components are needed for the mitotic-
to-endocycle transition (Deng et al., 2001; Schaeffer et al.,
2004). One such Notch-regulated component, essential for
the mitotic-to-endocycle transition is Hec1/CdhFzr, a WD40-
domain regulator of the APC-Ubiquitination complex.
Hec1/CdhFzr, which acts with other cellular components
important for M-phase entry, is dispensable for mitosis but
essential for the mitotic-to-endocycle transition in follicle cells
(Schaeffer et al., 2004). However, cells in fzr–/– clones do not
prolong mitosis unless accompanied with ectopic string.
We have now shown that this APC regulator is sufficient to
induce, albeit with low penetrance, premature endocycles if
precociously expressed in the follicle cell epithelium. We
furthermore identify an inhibitor of the CyclinE/CDK
complex, Dacapo, that is reduced because of Notch activity in
the mitotic-to-endocycle transition as a repressor of endocycles
in follicle cells. Notch activity, therefore, executes the mitotic-
to-endocycle transition by regulating three cell cycle
transitions: repression of String blocks M-phase, activation of
Hec1/CdhFzr allows G1 progression, and repression of Dacapo
assures entry into S-phase.
Materials and methods
Fly stocks
The following fly stocks were used: FRT82B Dlrev10e (Dlrev10 is an
amorphic allele of Delta that is produced by excision of the promoter
region, transcription start site and first exon) (Heitzler and Simpson,
1991; Zeng et al., 1998); Su(H) FRT40A [Su(H)SF8 is a strong loss-
of-function but not a null allele of Suppressor of hairless, a gift from
S. Blair), whereas Su(H)047 FRT40A is a null allele] (Li et al., 1998);
fzrie28 FRT101 (Schaeffer et al., 2004); FRT42B dap4 [dap4 is a w–
derivative associated with 95%-100% lethality, which was found to
represent an imprecise excision that resulted in an intragenic deletion
of the dacapo gene] (Lane et al., 1996), ago1 FRT80B, ago3 FRT80B
and ago4 FRT80B all have similar archipelago phenotypes (Moberg
et al., 2001). For generating follicle cell clones we used: hsFLP;Ubi-
GFP FRT40A, hsFLP;Ubi-GFP FRT42B, hsFLP;lacZ FRT42B,
hsFlp;;Ubi-GFP FRT80B, hsFlp;;FRT82B Ubi-GFP, yw Ubi-GFP
FRT101, w–;;MKRS P{ry=hsFlp}86E/Tm6BTb, hsFlp;;UAS-
GFPact<FRT-CD2-FRT<Gal4/TM3 (Pignoni and Zipursky, 1997).
For analysis of overexpression patterns the following stocks were
used: UAS-stgN4 and UAS-stgN16 (Bloomington Stock Center/Bruce
Edgar), UAS-inx2 (Stebbings et al., 2002), mewD .Scer\UAS (Li et al.,
1998), w–;UAS-cycD/CyOGFP;Dichaetae/TM6B, UAS-cycE, UAS-
cycA, UAS-dap II.2 and UAS-dap II.3 (gifts from Bruce Edgar), UAS-
fzr III.2, UAS-fzr II.1, fzrie28 (gifts from Christian Lehner) and w;
UAS-dMyc132, a gift from Robert Eisenman (Johnston et al., 1999).
We also used the following p53 lines: w[1118];P{w[+mC]=GUS-
p53}2.1, dominant negative constructs of p53 w[1118];P{w[+mC]=
GUS-p53.259H}3.1 and w[1118];P{w[+mC]=GUS-p53.Ct}3.1/
TM6B, Tb[1] (Bloomington Stock Center/Gerry Rubin), and the p53
viable mutants y[1]w[1118];p53[5A-1-4] and y[1]w[1118];p53[11-
1B-1] (Bloomington Stock Center/Kent Golic). Rbf120a/FM7 and
Rbf14/FM7 were gifts from Giovanni Bosco and Terry Orr-Weaver. In
addition, we used the fzr-lacZ fusion line G0326 (Bloomington Stock
Center), 6.4-string-lacZ fusion transgene construct [a gift from Bruce
Edgar (Lehman et al., 1999)] and various dap transgene constructs
[gifts from Christian Lehner (Meyer et al., 2002) and Harold Vaessin
(Liu et al., 2002)]. dap-lacZ fusion transgene constructs that lacked
the 1.5 kb upstream region of the dap gene gave no staining, however,
most of the dap-gm constructs, which included the entire gene as well
as different lengths of the promoter region fused to a myc-epitope tag,
showed clear staining in the follicle cells before stage 6 and a
downregulation of expression thereafter.
Generation of follicle cell clones
Drosophila melanogaster stocks were raised on standard cornmeal-
yeast-agar-medium at 25°C. To obtain follicle cell clones, 1-to-5-day-
old flies were heat-shocked as adults for 50-60 minutes at 37°C and
put in freshly yeasted vials for 3 or 5 days. To obtain germ line clones,
flies were heat-shocked as second and third instar larvae for 2 hours
on 2 consecutive days. Once they emerged as adults, they were placed
in vials with fresh yeast paste for 1-5 days prior to dissection.
Nuclear preparation and flow cytometric analysis
Nuclear preparation was done essentially as described in Bosco et
al. (Bosco et al., 2001) and Calvi and Lilly (Calvi and Lilly, 2004)
with minor modifications. Ovaries from 50-100 females were
incubated in 1 ml of 5 mg/ml collagenase (Blend type H, Sigma-
Aldrich C8051) in 90% Graces insect medium at 4°C for 15 minutes
on a Clay-Adams Nutator. Ovaries were then disrupted by pipeting
them several times through a P-1000 tip and then pelleted in an
Eppendorf centrifuge by a 2-second spin at 1000 g. The pellet was
resuspended in 500 m l of buffer A (15 mM Tris-HCl, pH 7.4, 60 mM
KCl, 15 mM NaCl, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM
spermine, 0.5 mM spermidine) plus 0.25 M sucrose and 0.5% NP-
40. Next the ovaries were homogenized at 4°C by 10 strokes in a 2
ml Kimble/Kontes glass dounce with a glass B-clearance pestle. The
resulting lysate was cleared by serial passage through 150-, 100-,
50- and finally 30- m m Nitex filters (Sefar America, Depew, NY,
USA). Nuclei were then pelleted by passage through a sucrose (0.25
M-2.5 M, in 1X Buffer A) density step gradient 15,000 g for 20
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minutes at 22°C in a Beckman TLS-55 rotor and resuspended in 200
m l of buffer A that contained 0.1% NP-40 and 20 m g/ml propidium
iodide. Follicle cells nuclear ploidy was determined by fluorescence-
activated cell sorting (FACS) analysis using a Becton Dickinson
FACScan cytometer by numbering the intensity of propidium
fluorescence in stained nuclei. Nuclei were exited with a 488 nm
laser, and the emission was monitored through a 585/42 nm band
pass filter. Results were analyzed by using CellQuest and Multicycle
software.
Staining procedures
Ovaries were dissected in phosphate-buffered saline (PBS) and fixed
while shaking on a nutator for 10 minutes in PBS containing 5%
Formaldehyde. Next, they were rinsed with PBT (PBS/0.2% Triton
X-100) four times (15 minutes, each rinse) and blocked in PBTB
(PBT, 0.2% BSA, 5% Normal Goat Serum) for one hour at room
temperature. The tissue was incubated with primary antibodies
overnight at 4°C. The next day they were rinsed with PBT four times
(15 minutes, each rinse) and blocked in PBTB for one hour at room
temperature. The ovaries were then incubated in secondary
antibodies overnight at 4°C. The next day they were rinsed with PBT
(4 · 15 minutes) and stained with DAPI (1 m g/ml in PBT) for 10
minutes. Finally, they were washed with PBT twice four times (5
minutes, each wash) and dissected onto slides in 70% glycerol, 2%
NPG, 1X PBS.
Follicle cells were labeled with BrdU as described previously
(Bosco et al., 2001; Calvi and Lilly, 2004; Lilly and Spradling, 1996)
with slight modifications. Ovaries were dissected in Grace’s insect
medium and then incubated with 10 m M BrdU (Boehringer
Mannheim) in the same medium for 1.5 hours at room temperature.
The ovaries were then fixed in 10.5% formaldehyde for 15 minutes,
washed with PBT, then treated with 2N HCl for 45 minutes. Sodium
borate (100 mM) was used for neutralization. The tissues were then
rinsed with PBT three times (10 minutes, each rinse) and blocked in
PBTB for half an hour at room temperature and incubated with mouse
anti-BrdU antibodies (Becton Dickinson) overnight at 4°C. The next
day, ovaries were rinsed with PBT six times (5-10 minutes, each
rinse), blocked in PBTB for 30 minutes at room temperature and
incubated with secondary antibodies for 2 hours at room temperature.
Thereafter, the ovaries were rinsed with PBT four times (15 minutes,
each rinse) and stained with DAPI for 10 minutes. Finally, they were
washed with PBT twice (5 minutes, each wash) and dissected onto
slides in 70% glycerol, 2% NPG, 1X PBS.
Confocal microscopy, X-gal staining and in situ hybridization were
performed as described previously (Keller Larkin et al., 1999;
Tworoger et al., 1999). For in situ RNA hybridization studies stg
cDNA (LD47579) was labeled with fluorescine, whereas cycD
(LD22957), cycE (LD22682), cycA (LD44443), cycB (LD23613), and
fzr (LD21270) cDNAs were labeled with digoxigenin (all cDNAs
were from the Berkeley Drosophila UniGene Collection). A two-
photon laser-scanning confocal microscope (Leica TCS SP/MP) was
used in this study.
The following primary antibodies were used at the designated
dilutions: mouse anti-Fasciclin III (1:20), mouse anti-CycA (1:20)
and mouse anti-CycB (1:20) from Developmental Studies
Hybridoma Bank, rabbit anti-CycA [1:100, David Glover (this
antibody showed CycA downregulation at stage 6 but some
immunoreactive material was later observed at stage 8)], mouse anti-
CycE (1:5, a gift from Helena Richardson), guinea pig anti-CycE
(1:500, a gift from Terry Orr-Weaver), rabbit anti-PH3 (1:200,
Upstate Biotechnology), rabbit anti-Fizzy-related (1:800, a gift from
Christian Lehner), mouse or rabbit anti- b -gal (1:5000, Sigma) and
mouse anti-c-Myc (1:50, Calbiochem). The following secondary
antibodies were used at the designated dilutions: Alexa 488, 568 or
633 goat anti-mouse (1:500), Alexa 488, 568 or 633 goat anti-rabbit
(1:500, Molecular Probes), Alexa 488 goat anti-guinea pig (1:500,
Molecular Probes).
Studying the Cyclin D role in mitotic-to-endocycle
transition
We analyzed the expression pattern of CycD during mitotic-to-
endocycle transition, because it has been shown to be critical for cell
growth in Drosophila (Chen et al., 2003; Datar et al., 2000; Meyer et
al., 2000) and the cell growth is a major component of endocycle.
Surprisingly, a clear downregulation of cycD RNA level was observed
at the onset of endocycles, stage 6 (data not shown). The functional
relevance of this downregulation is not clear because overexpression
of the protein, in combination with its kinase Cdk4, does not
dramatically affect entry into endocycles. During these
overexpression studies, we observed no difference in the size of nuclei
compared with those in wild-type cells and there was no upregulation
of CycB or PH3 (data not shown).
Results
The endoreplication cell cycle or endocycle is a variation of
the normal mitotic cell cycle, in which cells increase their
genomic DNA content without dividing. How the transition
from the mitotic cycle to the endocycle is regulated is not well
understood. Drosophila oogenesis provides an excellent
system in which to study this transition (Calvi et al., 1998).
In the Drosophila ovary both the germ line and somatic cells
arise from stem cell populations located in an anterior ovary
structure called the germarium (Fig. 1A). At the posterior end
of the germarium, somatic cells encapsulate a 16-cell cyst
of germ line cells, a configuration in which the oocyte
will eventually develop during a three-day period (this
developmental process has been divided into 14 stages).
Meanwhile, the somatic follicle cells will undergo three tightly
developmentally controlled cell cycle modifications (Calvi et
al., 1998). First, these epithelial cells undergo a mitotic division
program that gives rise to approximately 1000 follicle cells by
stage 7 in oogenesis (Fig. 1A, part I). At this mid-oogenesis
point, signaling through the Notch pathway stops the mitotic
cycles in the follicle cells and allows them to enter
endoreplication to become polyploid (Deng et al., 2001;
Lopez-Schier and St Johnston, 2001) (Fig. 1A, part II). After
stage 6, the follicle cells then undergo three endocycles to
become polyploid. Later in oogenesis at stage 10B in response
to unknown developmental signals, four different loci,
encoding several different genes two of which are chorion
genes, synchronously initiate a gene amplification event, that
increase their copy number (Fig. 1A, part III). During this
phase all other genomic replication origins remain inactive
(Orr-Weaver, 1991; Spradling, 1999). The chorion genes
encode the eggshell proteins and amplification of these genes
is needed to produce sufficient chorion protein for a normal
eggshell. These three replication patterns are readily observed
by BrdU analysis (Calvi et al., 1998) (Fig. 1B). In addition,
these cell cycle programs can be distinguished by different
markers, for example, CycB and PH3 (Deng et al., 2001) (Fig.
1C).
Hec1/CdhFzr is sufficient to stop mitosis and induce
premature endocycles
We have previously described the role of Notch signaling in
downregulating string at stage 6 of oogenesis to allow the cells
to transit into the endocycle (Deng et al., 2001) (Fig. 1D). In
order to find other cell cycle genes activated by Notch activity
after/during the transition from mitotic-to-endocycle, we
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performed an expression screen for genes differentially
expressed before and after the transition. We screened 400
lethal X-chromosome P-element enhancer trap-lines (Peter et
al., 2002) for changes in expression levels at stage 7 using the
b -gal reporter gene. Seven genes that fall into three interesting
functional groups were obtained from this screen: adhesion
molecules, transcriptional control proteins and cell cycle
regulators (Table 1). The two cell cycle regulators, Fizzy
related (Hec1/CdhFzr) and Myc (Bourbon et al., 2002), were
analyzed in more detail. The expression of string is observed
until stage 6, whereas high fizzy related ( fzr) expression marks
the start of endocycles (Fig. 1D,E). Importantly, we have
shown that Hec1/CdhFzr is required for the
mitotic-to-endocycle transition in these cells
(Schaeffer et al., 2004). Furthermore, we have
shown that the combination of reduced
Hec1/CdhFzr and prolonged Stg expression
can keep the follicle cells in the mitotic cycle
past stage 6.
To test what is required to turn mitotic
cycles to endocycles prematurely, we over-
expressed candidate genes at stages 1-6
and analyzed the effects in follicle cells
undergoing mitotic cycles. Premature
expression of the adhesion molecules did not
alter the timing of the mitotic-to-endocycle
transition (Table 1). However, premature
expression of the Notch-responsive cell
cycle component, Hec1/CdhFzr, caused the
formation of enlarged nuclei, a potential
indication of precocious endocycles (Fig.
2A,B) (Schaeffer et al., 2004). Importantly,
analysis of cell cycle markers revealed a
premature reduction of cyclins A and B (70%
and 91% reduction, respectively; Fig. 2C).
Consequently, a halt in mitotic cell cycle (60%
reduction in PH3 staining; Fig. 2C) was
observed because of the premature expression
of Hec1/CdhFzr. In contrast, as a control we
overexpressed other cell cycle components,
such as dMyc and p53 and observed no change
in the expression of mitotic markers compared
with that seen in wild-type cells (Fig. 2C).
These findings suggest that the premature
expression of Hec1/CdhFzr is sufficient, at
least partially, to stop mitosis.
The enlarged nuclei observed upon
overexpression of Hec1/CdhFzr could be
caused via a ploidy-independent mechanism
(Gao and Pan, 2001; Tapon et al., 2001) or via
increase in ploidy as some cells undergo
ectopic endocycles. To distinguish between
these possibilities, we determined the exact
DNA content in the cells overexpressing fzr by
FACS on purified ovarian nuclei (Bosco et al.,
2001; Calvi et al., 1998; Lilly and Spradling,
1996). Although control nuclei revealed the
normal 2n, 4n, 8n and 16n DNA peaks, some
of the nuclei from UAS-fzr mutants showed
DNA content of 32n, comparable with that in
Rbf mutants, in which follicle cells are known
to undergo extra endocycles (Bosco et al.,
2001) (Fig. 2H-J). These data suggest that
some of the follicle cells overexpressing fzr
not only stopped mitotic cycles prematurely
but also proceeded through extra endocycles
increasing the ploidy of the cells.
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Fig. 1. Cell cycle transitions in epithelial follicle cells. (A) Follicle cells in Drosophila
oogenesis undergo two cell cycle transitions: from a mitotic cell cycle to an endocycle
and from endocycle to amplification (A, parts I-III, drawing of the stages of oogenesis).
From the germarium (g) to stage (st) 6, somatically derived follicle cells undergo
mitotic cycles, which are not synchronized (A, part I). At stage 7 they switch to
endocycles. From stage 7 to stage 10A, these cells undergo three rounds of
endoreplication (A, part II) and thereafter switch to the localized replication pattern
characteristic of chorion gene amplification (A, part III). These three replication
patterns are observed in BrdU incorporation analysis (B). The staining of mitotic
markers Cyclin B (CycB) (red arrows), Phospho-Histone 3 (PH3) (green arrows) (C)
and stg (6.4) promoter construct (D) show expression in mitotic follicle cells, whereas
Fzr enhancer trap line, fzrG0326 (b -gal expression, red arrow) shows Fzr expression in
endocycling cells (E). Green, PH3; red, CycB (C); Anti- b -gal (D,E); blue, DAPI (C-E).
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Fig. 2. Fzr is partially sufficient to induce
precocious endocycles, dMyc to
accelerate endocycles. Ectopic expression
of fzr (hsFlp; UAS-fzr; UASGFP
act<FRT-CD2-FRT<Gal4) reduces CycA
and B levels, stops mitosis (A,B) and
allows the formation of large nuclei (B)
indicative of precocious endocycles prior
to stage 6 in oogenesis. The diagram in C
presents the percentage of the wild-type
and mutant follicle cells that show
positive staining to mitotic markers
during the mitotic stage. fzr (D,F,J) and
myc (E,G,K) overexpression (hsFlp; UAS-
fzr or UAS-myc; UASGFP act<FRT-CD2-
FRT<Gal4) generate enlarged nuclei,
which is indicative of abnormal
endocycles but do not affect the
amplification stage because normal BrdU-
incorporation pattern at stage 10B-12 (red
arrows) is observed in cells
overexpressing fzr (F) and myc (G). (H-K)
FACS profiles of DNA content in UAS-fzr
(J) and UAS-myc (K) mutant nuclei
compared with these in WT nuclei (H)
show the appearance of a cell population
that has 32n DNA, also observed in Rbf
mutants (I) (Bosco et al., 2001). Green,
GFP (A,D,E), Fzr Ab (F); red, CycB (A),
DAPI (D,E), BrdU (F,G); blue, DAPI
(A,F,G).
Table 1. Genes that show a change in expression levels at the mitotic-to-endocycle transition in follicle cells
Cell cycle phenotypes 
Functional group Protein Expression Loss of function Ectopic expression
Adhesion Fasciclin 2 After stage 7-8 N/A N/A
Innexin 2 After stage 7-8* N/A No phenotypes (this study)
PS1a (mew) After stage 7-8 N/A No phenotypes (this study)
Transcriptional control BRC After stage 7-8 Abnormal amplification (Tzolovsky et al., Abnormal amplification (Tzolovsky et al., 
1999) 1999)
Trf2 After stage 7-8 N/A N/A
Cell cycle control Fzr After stage 7-8 Defective endocycle (Schaeffer et al., 2004) Precocious endocycle (this study)
Myc After stage 7-8 Defective endocycle (Maines et al., 2004) Accelerated endocycle (this study)
*mRNA expression pattern of innexin 2 in Drosophila follicle cells has been previously described (Stebbings et al., 2002).
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Ectopic Hec1/CdhFzr affects mitotic-to-
endocycle but not endocycle-to-amplification
transition
After three rounds of endocycles, the follicle cells
synchronously initiate a chorion gene amplification event
that continues to increase the copy number of four
different loci. The amplification occurs by the initiation
of repeated rounds of DNA replication and fork
movement to produce a gradient of amplified DNA
extending ~100 kb (Calvi and Spradling, 1999; Orr-
Weaver, 1991). How the onset of the endocycle-to-
amplification transition is regulated is not understood.
To further analyze whether the larger nuclei observed
upon ectopic fzr expression was because of precocious
endocycling during the mitotic phase and/or prolonged
endocycling during the amplification phase, we analyzed
whether the amplification stage was defective or delayed
in cells that overexpressed fzr. BrdU incorporation
revealed normal amplification patterns in control and fzr-
overexpressing cells (Fig. 2F), suggesting that the extra
endoreplication observed upon fzr overexpression was
not caused by defects in the endocycle-to-amplification
transition. We therefore conclude that the larger nuclei
arose because of a premature switch in the timing of the
mitotic-to-endocycle transition.
Myc in the mitotic-to-endocycle transition
Premature expression of Fzr is sufficient to halt mitotic
cell cycles 60% of the time, however, only one-third of
these cells will enter premature endocycles (Fig. 2B,C).
One possible explanation for these results is that
components at G1/S transition, such as G1 cyclins,
further restrict from entering the premature endocycles
by blocking entry into the S-phase in mitotic cells.
In other systems G1/S transition is controlled in part
by factors that regulate cell growth such as CycD or Myc
(Frei and Edgar, 2004). Curiously, CycD does not seem
to be critical for endocycles in follicle cells (see
Materials and methods). This presents a paradox because
CycD is known to be critical for cellular growth in
Drosophila (Datar et al., 2000; Meyer et al., 2000) and
a key feature of all endocycles is an increase in cell size.
Interestingly, the expression screen described previously
(Table 1) (Bourbon et al., 2002) might provide an answer
to this apparent paradox, because this screen demonstrated
that Myc, another component required for growth, is
transcriptionally upregulated at the transition.
dMyc is the Drosophila homologue of the BHLHZ Myc-
oncogene family of transcription factors. Recent studies have
shown that dMyc has a function in cellular growth (Iritani and
Eisenman, 1999; Johnston and Gallant, 2002; Johnston et al.,
1999). To test whether dMyc can influence the mitotic-to-
endocycle transition, we overexpressed dmyc in developing
follicle cells and analyzed cell cycle markers in both cell cycle
programs. No obvious change was observed during the mitotic
stage upon ectopic expression of dmyc (Fig. 2C); however
during the endocycling stage, cells overexpressing dmyc were
larger than the neighboring wild-type cells (Fig. 2E). In
particular, larger nuclei were observed in 32% and 55% of the
cells at stage 7-9 and 12 (respectively) after overexpressing
dmyc (Fig. 2B). FACS analysis revealed that these large nuclei
were indicative of extra endocycles because cells with 32n
ploidy were observed among these follicle cells (Fig. 2K).
Similar to the case of fzr overexpression, BrdU incorporation
revealed normal amplification patterns during stage 12 in
oogenesis in cells overexpressing myc (Fig. 2G), suggesting
that the extra endoreplication observed during myc
overexpression was not caused by defects in the endocycle-
to-amplification transition. Because the higher ploidy
accompanies no change in the timing of mitotic-to-endocycle
or endocycle-to-amplification transition, we conclude that this
defect was caused by faster endocycle kinetics than in wild-
type follicle cells. Thus, these data suggest that Myc-dependent
growth can regulate endocycle kinetics in follicle epithelial
cells.
Proper CycE regulation is required for the mitotic-to-
endocycle transition
Another G1/S-regulator that might play a role in the proper
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Fig. 3. The Cyclin E levels are dynamic during cell cycle transitions;
constant CycE levels halt endocycles and amplification. (A) Wholemount
in situ hybridization indicates equal level of cyclin E mRNA in the follicle
cells throughout oogenesis (arrows). (B,C) Cyclin E antibody staining
pattern (green) between stages 5 (B) and 8 (C) shows a clear
downregulation of the protein after the transition to the endocycle, when
cells stop expressing PH3 (red). Cells overexpressing CycE (hsFlp;;UAS-
cycE/UASGFP act<FRT-CD2-FRT<Gal4) express mitotic cyclins B and A
past stage 6 in oogenesis (D-E, arrow), have smaller nuclei (F,F¢ ) and show
highly reduced BrdU incorporation during endocycling (G,G ¢ ) and
amplification (H,H¢ ) stages, suggesting that cells ectopically expressing
cyclin E fail to undergo S-phase and are halted at G2. Green, CycE (B,C),
GFP (D-F), BrdU (G,H); red, PH3 (B,C), CycB (D), CycA (E), CycE (F-
H); blue, DAPI.
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mitotic-to-endocycle transition in follicle cells is Cyclin E
(Calvi et al., 1998). Drosophila Cyclin E forms a complex with
the DmCdc2c/Cdk2 kinase and controls the progression
through the S phase; its downregulation limits embryonic
proliferation and its oscillation is required for endocycling
(Follette et al., 1998; Knoblich et al., 1994; Weiss et al., 1998).
The cycE mRNA expression pattern in the follicle cells during
oogenesis reflects a continuous requirement both in mitotic and
endocycles without downregulation at the mitotic-to-endocycle
transition; but rather, an equal level of ‘patchy’ cycE mRNA
levels within the follicle cells throughout oogenesis (Fig. 3A).
The same ‘patchy’ pattern of CycE protein level is seen in
mitotic and endocycling follicle cells, indicating the cell cycle-
dependent oscillation of CycE protein. However, we observed
a clear, but not complete, downregulation of CycE protein
levels at approximately stage 7, just after the follicle cells
stopped expressing CycB and PH3 (mitotic markers) (Fig.
3B,C). In follicle cell clones mutant for a transcription factor
in the Notch pathway, Su(H), the CycE levels were somewhat
abnormally regulated during endocycles, which suggested a
role for the Notch signaling pathway in this posttranscriptional
regulation (data not shown).
The observed change of CycE level in the mitotic-
to-endocycle transition is critical because continuous
overexpression of CycE leads to abnormalities in the mitotic-
to-endocycle transition; the cells of clones overexpressing cycE
exhibit prolonged expression of CycA and CycB and have
smaller nuclei than their neighbours (44% and 63%,
respectively; n=214) (Table 2, Fig. 3D-F) (Lilly and Spradling,
1996). However, no PH3 staining is observed among these
mutant cells after stage 6, suggesting that they do not undergo
prolonged mitosis. Likewise, BrdU incorporation is inhibited
in these cells after stage 6 (including the amplification stage as
shown before by Calvi et al. (Calvi et al., 1998), implying that
they also fail to undergo S-phase (Fig. 3G,H). Taking into
account these findings and the upregulation of CycB and CycA,
but lack of PH3 staining, we hypothesize that the cells
overexpressing CycE are halted at the G2 stage of the cell cycle
in the mitotic-to-endocycle transition.
These and other data (Calvi et al., 1998; Lilly and Spradling,
1996; Sauer et al., 1995) suggest that correct CycE protein
levels are critical for the proper mitotic-to-endocycle
transitions. We therefore turned our investigation to the role
of two regulators of CycE protein: Dacapo, a CIP/KIP
homologous protein found to inhibit CycE activity (de Nooij
et al., 2000; Lane et al., 1996) and Archipelago, a recently
characterized F-box, WD repeat protein found to target CycE
for SCF-dependent degradation (Moberg et al., 2001;
Strohmaier et al., 2001).
Dacapo downregulation by Notch signaling at
mitotic-to-endocycle transition is required for proper
endocycling
The Cip/Kip families of cyclin-dependent kinase inhibitors
(CKI) are the main effectors linking developmental programs
and cell cycle progression (Liu et al., 2002). Drosophila
dacapo (dap) encodes an inhibitor of cyclin E/cdk2 complexes
with similarity to the vertebrate Cip/Kip inhibitors (Lane et al.,
1996; Liu et al., 2002; Meyer et al., 2002) and thereby inhibits
entry into the S-phase. In accordance with this role,
mammalian family members are upregulated during
checkpoint activation and are expressed in terminally
differentiated tissues. Dacapo contains a conserved amino-
terminal domain that binds to and inhibits all kinases involved
in G1/S transition. This inhibition is achieved by a
conformational change in the cyclin/Cdk complex (Pavletich,
1999).
In follicle cells, the in situ mRNA hybridization pattern for
dacapo indicates that its transcriptional level is downregulated
at stage 6-7 (Fig. 4A), suggesting a potential regulation by the
Notch pathway. Because dacapo has previously been shown
to be developmentally controlled by an extensive promoter
region, we used different dap-constructs (Liu et al., 2002;
Meyer et al., 2002) and studied their expression patterns in the
follicle cells during oogenesis. The smallest constructs, that
faithfully represent dacapo mRNA pattern (dap5gm and
dap6gm), include the entire gene as well as 1.8 kb and 2 kb
of the promoter region fused with a myc-epitope tag. These
transgenic lines showed clear myc-epitope staining in the
follicle cells before stage 6 and a downregulation of expression
thereafter (Fig. 4B). One of these constructs, dap5gm, was used
as a marker for Dacapo expression in the following studies.
In order to determine whether Notch signaling controls the
downregulation of dacapo at stage 6, we analyzed Dacapo
expression in follicle cells surrounding Delta mutant germ line
clones in a fly that contained the dap5gm construct. In the Dl
germ line clones, we clearly observed a prolonged expression
of dap5gm in stages later than 6 (Fig. 4C), suggesting that the
transcriptional downregulation of dacapo is dependent on
Notch activity.
Table 2. Proper Cyclin E regulation is crucial for endocycles: increased Cyclin E activity blocks the cells in G2, reduced
Cyclin E in G1
Cell cycle phenotypes at stage 7-12 follicle cells*
Small nuclei Prolonged staining of mitotic markers BrdU incorporation
Genotype (lack of endocycles) (CycA,B) (CycE) PH3 Endocycles† Amplification Cell cycle arrest
hsFlp;; UAS-cycE/UASGFP act + 63% + 44% + – – – G2
<FRT-CD2-FRT<Gal4
hsFlp: ago FRT80B/Ubi-GFP + 92% + 37% + 91% – – – G2
FRT80B
hsFlp; UAS-dap;UASGFP act + 71% – + activity (–) – – – G1
<FRT-CD2-FRT<Gal4 
Wild type – – – – + + No arrest
*n>100 cells for each experiment
†Although in wild type, 38% of all endocycling follicle cells are BrdU positive, in mutant clones only 6-7% of the cells showed BrdU staining.
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To analyze whether the Notch-dependent repression of
dacapo was important for the mitotic-to-endocycle transition,
we tested the functional consequence of dacapo loss-of-
function and prolonged expression for follicle cell cycle
control. Dacapo loss-of-function clones revealed no obvious
phenotype; nuclei sizes were normal and endocycle did not
appear to be inhibited. Overexpression of dacapo has
previously been shown to inhibit entry into late amplification
(Calvi et al., 1998) and, in the salivary gland, overexpression
of dacapo inhibits endoreplication (Weiss et al., 1998). We
likewise observed cell cycle defects because of the prolonged
expression of dap: smaller nuclei and a failure to incorporate
BrdU, indicating a lack of S-phases (Fig. 4D-F). CycA and
CycB, although upregulated in cells overexpressing CycE past
stage 6, were not upregulated in cells overexpressing dap
(Table 2). These results suggest that Notch-based
downregulation of dacapo is critical for endocycling because
overexpression of dacapo, a CIP/KIP-type cyclin-dependent
kinase inhibitor of Cdk2/CycE complexes, can halt the follicle
cell endocycles at the apparent G1/S transition. Also, one
possibility is that Dacapo in mitotic cells aborts premature
attempts to enter endocycles and precocious expression of
Hec1/CdhFzr (Fig. 2A,C).
Ago is essential for endocycles but dispensable for
mitotic cycles
Because dacapo is downregulated after the mitotic-to-
endocycle transition, we investigated whether archipelago, a
second regulator of CycE protein level was required for proper
oscillations of CycE during endocycles. Archipelago is an F-
box protein with seven tandem WD repeats that recognizes
auto-phosphorylated CycE. Ago protein binds directly to
Cyclin E and targets it for ubiquitin-mediated SCF-dependent
degradation (Moberg et al., 2001; Strohmaier et al., 2001). The
in situ hybridization pattern of archipelago reveals continuous
mRNA expression both in the mitotic and endocycling stages
(Fig. 5A). To investigate the role of Archipelago in these cells
we made follicle cell clones with three different ago alleles
(Moberg et al., 2001). As expected, we saw an increase in CycE
protein in most mutant follicle cells at all stages during
oogenesis in all three mutants (Fig. 5B). We then analyzed the
effect these mutations had on both mitotic and endocycling
cells. Based on phenotypic analysis in the Drosophila
eye, we might expect overproliferation of cells mutant
for ago (Moberg et al., 2001). Yet, we observed no
obvious defects in the control of mitotic divisions in
ago clones: the ratio between the number of cells in
sister clone versus mutant clone was 1:0.9 (n=14) and
the BrdU incorporation and CycA and CycB levels
during mitotic divisions were normal (Fig. 5D and data
not shown). In addition, the expression patterns of PH3
and String in ago clones were indicative of a normal
halt in mitotic cycles at stage 6 (Fig. 5C).
However, lack of Ago activity seemed to be
detrimental for entering the endocycle: ago clones
showed much reduced or no BrdU incorporation and
small nuclei size after stage 7 (Fig. 5F,G, Table 2). In
addition, CycB expression is prolonged in 37%
(n=200) of ago-mutant follicle cells past stage 6 (Fig.
5E). We also analyzed CycA, a marker of the S and G2
phase, and observed an elevation in ago clones (data
not shown). At the later stages no amplification was
observed and some of the mutant cells were seemingly
apoptotic (Fig. 5H and data not shown). The
phenotypes in ago-clones (elevation of CycA and
CycB levels, small nuclear size, lack of endocycle and
amplification and some cell death at late stages) are
also observed upon overexpression of CycE and were
indicative of a G2 block (Fig. 3D-H, Table 2). Because
overexpression of CycE is observed in most cells
mutant for ago, we conclude that the phenotypes
observed during the mitotic-to-endocycle transition in
ago clones could be because of the high level of CycE
activity. These data suggest that an Archipelago/SFC-
dependent regulation of CycE protein levels is
dispensable for mitotic divisions but essential for
endocycles in follicle epithelium.
Notch controls independently String,
Hec1/CdhFzr and Dacapo expression
Notch activity affects the expression of Stg (Deng et
al., 2001), Fzr (Schaeffer et al., 2004) and Dacapo (this
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Fig. 4. Notch-dependent repression of the Cyclin E inhibitor Dacapo is
required for mitotic-to-endocycle transition. (A) The dacapo mRNA in situ
pattern indicates transcriptional downregulation after transition to endocycles
(light arrow, st. 7). (B) A similar expression pattern was observed in a
dap5gm construct, which includes the entire gene and a part of the promoter
region fused with myc-epitope tag (arrow indicates follicle cells staining
prior to st. 7). (C,C ¢ ) Prolonged follicle cell expression of dap5gm in st. 9
Delta germ line clone shows that dap is controlled by Notch signaling. (D)
Overexpression of dap (hsFlp; UAS-dap; UASGFP act<FRT-CD2-
FRT<Gal4) inhibits endoreplication: follicle cells overexpressing dacapo
have smaller nuclei (D¢ ) than the neighboring wild-type cells and they fail to
incorporate BrdU during both the endocycling (E,E ¢ ) and the amplification
(F,F¢ ) stages, indicating that these cells could not undergo the S-phase and
probably are blocked at the G1/S transition. Green, GFP (C,D), BrdU (E,F);
red, CycE (D), Dap (E,F); blue, DAPI.
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study) at the mitotic-to-endocycle transition in
follicle cells. Because cell cycle regulators can
control each other (Futcher, 2002), we tested
whether changes in these three Notch-dependent
cell cycle regulators lead to changes in each
other’s expression levels. In this scenario one of
the targets might be the primary responder,
whereas the others would be downstream
components of the pathway.
In particular, because Hec1/CdhFzr loss-of-
function phenotype is similar to the phenotype
observed upon altering Cyclin E activity
(Schaeffer et al., 2004) (Figs 3, 4, 5), we tested
whether defects in Cyclin E levels can result in
downregulation of Hec1/CdhFzr. Overactivation
of Cyclin E (because of lack of ago function or
overproduction of CycE) blocks the endocycling
cells at G2, whereas inactivation of Cyclin E
(because of overproduction of Dacapo) blocks
them in G1 (Table 2). However, importantly,
neither of these alterations result in repressed
Fzr expression at the mitotic-to-endocycle
transition: cells that do not endocycle because of
overexpression of dacapo or cyclin E show
normal Hec1/CdhFzr levels at stages 7-9 (Fig.
6A,B). Based on these data, block of endocycles
by CycE or Dacapo overexpression does not
repress the expression of the endocycle
regulator, Hec1/CdhFzr. However accumulation
of CycA and CycB are observed upon Cyclin E
overexpression (Table 2, Fig. 3D,E), suggesting
that even though Hec1/CdhFzr is present it might
not be in an active form.
Premature expression of Hec1/CdhFzr blocks
mitotic cycles and induces premature endocycles
(Fig. 2A-E). Lack of string at stage 4-6 shows
similar phenotypes (Deng et al., 2001; Schaeffer
et al., 2004). We therefore analyzed whether
overproduction of Hec1/CdhFzr caused a
premature repression of String levels. However,
no effect on string (or dacapo) expression was
observed in cells that prematurely expressed fzr
and entered endocycles (Fig. 6C,D).
Based on these findings, no obvious feedback
regulation was observed between these cell cycle
regulators, disturbed CycE levels did not
block endocycles by repressing Hec1/CdhFzr
expression levels and premature Fzr does not
block mitosis by affecting String levels.
Therefore, these data suggest that the Notch-
dependent regulation of these targets is
independent of each other (Fig. 7A).
Discussion
To unravel how the Notch pathway allows follicle cells to
progress through the mitotic-to-endocycle transition we
previously identified Cdc25 Phosphatase/String as a
transcriptional responder to Notch activation. However,
overexpression of string is not sufficient to induce the ectopic
mitosis in all follicle cells past stage 6; it can only partly
prolong mitotic cycles in posterior follicle cells (Schaeffer et
al., 2004). This suggests that other critical factors are also
regulated in the transition. Interestingly, the regulator of APC-
ubiquitination complex, Hec1/CdhFzr, and the G1 cyclin CycE
inhibitor Dacapo are also regulated at the mitotic-to-endocycle
transition. Hec1/CdhFzr shows transcriptional activation,
whereas Dacapo is reduced at the transcriptional level.
We show that the Notch-dependent cell cycle regulator
Fig. 5. Ago is dispensable for mitosis but is required for endocycles in follicle cell
epithelium. (A) The ago mRNA is expressed in both mitotic and endocycling follicle
cells (arrows). (B) Ago is responsible for CycE degradation; follicle cells in ago
(hsFlp;; ago FRT80B/Ubi-GFP FRT80B) clones show increased level of CycE
protein at all stages during oogenesis. Ago loss-of-function does not affect the
mitotic cycles in follicle cells: ago clones showed normal expression pattern of stg
(C; expression prior to st. 6, red arrow, but not past st. 6, black arrow) and the ratio
between the number of cells in sister versus mutant clone was 1:0.9 (D). However,
ago clones halt the transition to endocycles: prolonged CycB expression (E,E ¢ ),
small nuclei size (F,F¢ ; clones marked with elevation of CycE levels) and highly
reduced BrdU incorporation during both endocycles (G,G ¢ ) and amplification (H,H ¢ )
are observed in ago clones. Green, GFP (B,C,E), BrdU (G,H); red, CycE (B, CycE
level marks the clones in F-H), b -gal (C), CycB (E); blue, DAPI.
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Hec1/CdhFzr, that is required for endocycles, is sufficient to
block mitosis and initiate precocious endocycling when
expressed prematurely. However, although the efficiency of
this process is 60%, only 20% of the cells enter premature
endocycles (Fig. 2C), which suggests that other components in
the G1-S transition might play a role. We also show that a
critical factor in the mitotic-to-endocycle transition, Cyclin E
level, is controlled by the posttranslational regulators: the
WD40-protein, Ago, and the Notch-responsive CDKI, Dacapo.
Lack of Ago activity or ectopic expression of dacapo lead to
a halt in cell cycle progression in the transition. Of these
two CycE regulators, only Dacapo is transcriptionally
downregulated at the transition by activation of the Notch
pathway. Therefore, Notch allows the follicle epithelial cells to
bypass the G1-S transition by downregulating the critical
checkpoint component p21/Dacapo. However, we have shown
that CycE oscillation remains critical for endocycling;
continuous high level of CycE expression blocks the cell cycle
in G2. The regulation of CycE levels is achieved by the
function of F-box/WD40-domain protein Ago/hCdc4 that
presumably binds to auto-phosphorylated CycE and directs it
to SCF-complex degradation: high levels of CycE and no
endocycling is observed in ago-clones. Interestingly, the
function of another G1 cyclin, CycD in growth regulation
might be compensated by Myc in endocycles, because we have
shown that Myc can affect the kinetics of endocycles. These
data show that Notch activity executes the mitotic-to-endocycle
transition by regulating independently all three mitotic
regulators: downregulating the G2
phosphatase Cdc25/String and the G1 CKI
p21CIP/Dacapo and upregulating the
APC activator Hec1/CdhFzr (Fig. 7B).
Repression of String blocks the M-phase,
activation of Fzr allows G1 progression and
downregulation of Dacapo assures entry
into S-phase (Fig. 7A).
Hec1/CdhFzr
The exit from mitosis and/or progression
through G1 requires the inactivation of
cyclin-dependent kinases, mediated by the
APC/C-dependent destruction of cyclins
(Sigrist et al., 1995; Sorensen et al.,
2001). APC/C is regulated by multiple
mechanisms, such as phosphorylation and
by spindle checkpoints. Key factors for
APC/C function and regulation are the WD
proteins Cdc20 and Hec1/Cdh. These
proteins seem to bind directly to substrates
and recruit them to the APC/C core
complex. Importantly, Cdc20 and
Hec1/Cdh bind and activate APC/C in a
sequential manner during mitosis. APC/C-
Cdc20 is activated at the metaphase/
anaphase transition, and gets replaced by
APC/C-Hec1/Cdh in telophase. This
second complex remains active in the
subsequent G1 phase.
In Drosophila the homologue of
Hec1/Cdh, Fzr, also induces the APC/C-
complex-dependent proteolysis of CycA
and B and is required for the G1-phase
progression (Jacobs et al., 2002; Sigrist and
Lehner, 1997). Fzr is required for cyclin
removal during G1 when the embryonic
epidermal cell or follicle epithelial
proliferation stops and the cells enter
endocycles (Schaeffer et al., 2004; Sigrist
and Lehner, 1997).
We now show that premature
Hec1/CdhFzr transcription in follicle cells is
sufficient to block mitosis and initiate
precocious endocycling. This suggests that
Fzr is a powerful player in the mitotic-to-
endocycle switch, yet regulation of other
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Fig. 6. The Notch pathway regulates Fzr independently from String and Dacapo.
(A) Although cells ectopicly expressing dacapo (arrowhead) do not undergo endocycles
and have smaller nuclei (arrowhead in A ¢¢ ), they express normal levels of Fzr (arrowhead
in A ¢¢¢ ) compared with wild-type cells (arrow) (hsFlp/fzrG0326; UAS-dap; UASGFP
act<FRT-CD2-FRT<Gal4). (B) The normal Fzr expression is observed in most cells
overexpressing dacapo (hsFlp/fzrG0326; UAS-dap; UASGFP act<FRT-CD2-FRT<Gal4)
or cyclinE (hsFlp/fzrG0326; UAS-cycE/UASGFP act<FRT-CD2-FRT<Gal4).
(C) Premature expression of fzr (arrowhead in C¢ ) causes precocious endocycles (large
nuclei, arrowhead in C ¢¢ ) but does not affect string expression (C ¢¢¢ , arrowhead indicates
UAS-fzr cells, arrow – wild-type cells). (D) No effect on string or dacapo expression was
observed upon premature expression of fzr (the diagram shows that UAS-fzr and wild-type
follicle cells show close to equal percentage of cells with Dacapo and String staining,
hsFlp; UAS-fzr/UASGFP act<FRT-CD2-FRT<Gal4;6.4-string-lacZ or dap5gm). Green,
GFP; red, b -gal; blue, DAPI.
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components is also required for the efficiency of this process.
Regulators of G1-S transition, such as Dacapo/CIP/KIP, which
also turns out to be a Notch-regulated component, possibly
abort premature attempts by follicle cells to enter the
endocycle.
CycD or Myc in growth control
Our data suggest that a component regulating growth and
thereby the kinetics of G1/S transition in follicle cell
endocycles is the Myc oncogene instead and independent of
CycD. In mammals c-Myc controls the decision to divide or
not to divide and thereby functions as a crucial mediator of
signals that determine organ and body size (Levens, 2003;
Trumpp et al., 2001). Interestingly, overexpression of dmyc
in follicle cells does not affect the mitotic cycles but induces,
instead, extra endocycles. Because the timing for entering and
exit from the endocycles has not changed, however, increased
ploidy is observed, we suggest that the rate of endocycles is
increased because of the overexpression of Myc. This finding
is in accordance with recent loss-of-function analysis on myc
in follicle cells, suggesting that myc mutant follicle cells
can make the transition from mitosis to the endocycle,
but that they can only very inefficiently support the
endocycle (Maines et al., 2004). Therefore, both loss-of-
function and overexpression experiments suggest that Myc is
an essential component for the proper rate of endocycles in
follicle cells.
Cyclin E in endocycles
In addition to Myc and Cyclin D, Cyclin E also plays an
important role in the regulation of the G1/S-transition. Cyclin
E binds to and activates the cyclin-dependent kinase Cdk2, and
thereby promotes the transition from G1 to S (Knoblich et al.,
1994). Oscillation of Cyclin E activity is a mechanism
responsible for the timely inactivation of this G1 cyclin/Cdk
complex and an arrest in cell proliferation. The oscillation of
Cyclin E level is controlled partly by a SCF-ubiquitin-
dependent proteolysis (Koepp et al., 2001; Moberg et al., 2001;
Strohmaier et al., 2001; Won and Reed, 1996). Fluctuations of
Cyclin E are critical for multiple rounds of endocycles (Follette
et al., 1998; Weiss et al., 1998).
Cyclin E is critical for endocycles in follicle cells as well,
and our analysis shows that the CycE level is controlled by an
SCF-regulator, F-box protein, Ago/hCdc4/Fbw7. Fbw7 (Ago)
associates specifically with phosphorylated Cyclin E, and
catalyzes Cyclin E ubiquitination in vitro (Koepp et al., 2001).
Depletion of Ago leads to accumulation and stabilization of
Cyclin E in vivo in human and D. melanogaster. This leads to
increased mitosis in certain mammalian and Drosophila cell
types. In addition, ago loss-of-function clones in the germ line
will cause extra mitotic divisions or, in contrast, cell cycle
arrest and polyploidy (Doronkin et al., 2003). However, we
have shown that increased Cyclin E levels observed in ago loss-
of-function mutant clones do not affect the mitotic cycles in
follicle cells but do halt the transition to endocycles that
normally occurs at stage 6.
Why is the function of Ago/hCdc4/Fbw7 critical to
endocycles but not to mitotic cycles in follicle epithelial cells?
A potential answer might reside in Dacapo, a CIP/KIP-type
inhibitor of Cyclin E/Cdk2 complexes that is regulated in the
mitotic to endocycle transition by activation of Notch pathway.
We have shown that dacapo is downregulated at mitotic-to-
endocycle transition because of Notch activation and ectopic
expression of dacapo represses endocycle progression. It is
plausible that during mitotic phases Ago and Dacapo share a
redundant role for regulating the Cyclin E activity level,
however, dacapo is downregulated by Notch pathway at the
time of mitotic-to-endocycle transition and at that point Ago
gains the critical role of sole regulator of Cyclin E protein
activity level. However, downregulation of Dacapo does not
readily explain the reduction of CycE levels observed in
mitotic-to-endocycle transition (Fig. 3C). We detected
elevation of CycE protein level in response to Dacapo
overexpression, pointing out that this CKI may stabilize CycE
in an inactive form. One possibility therefore is that less CycE
protein is observed after the Dacapo downregulation because
Dacapo is no longer stabilizing it.
Why is Dacapo downregulated at the time of endocycle
transition? Expression of Dacapo is important for proper cell
cycle regulation. For example, during vertebrate development,





























Fig. 7. The mitotic-to-endocycle transition in Drosophila follicle
cells is executed by Notch-dependent control of cell cycle regulators.
(A) A proposed scheme showing that the Notch pathway induces a
switch from the mitotic-to-endocycle by controlling the activity of
key cell-cycle regulators; cyclin-dependent kinases that control M-
and S-phase entry and the APC/ubiquitination complex that regulates
degradation of cyclins. Notch activity controls these regulators by
downregulating String and Dacapo, and activating Hec1/CdhFzr.
(B) The molecular model in which Notch activity executes the
mitotic-to-endocycle switch by regulating all three major cell cycle
transitions. Repression of String blocks M-phase, activation of
Hec1/CdhFzr allows G1 progression and repression of Dacapo
assures entry into S-phase.
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as cells exit the mitotic cycle and begin to terminally
differentiate. Also, reduced expression of p27Kip1 was
frequently shown to correlate with a poor prognosis in various
cancers (Fredersdorf et al., 1997; Geisen et al., 2003), and in
the absence of p21, DNA-damaged cells arrest in a G2-like
state, but then undergo additional S-phases without intervening
normal mitoses. They thereby acquire grossly deformed,
polyploid nuclei and subsequently die through apoptosis
(Waldman et al., 1996). Also, p21 elimination causes centriole
overduplication and polyploidy in human hematopoietic cells
(Mantel et al., 1999). In the Drosophila germ line Dap is
differentially regulated in the nurse cells versus the oocyte.
High Dap levels in the oocyte are critical to the maintenance
of the prophase I meiotic arrest and ultimately to later events
of oocyte differentiation, and in the nurse cells the oscillations
of Dap drive the endocycle (Hong et al., 2003). In contrast to
all these examples, in endocycling follicle cells reduction
of p21/Dacapo is a requirement for normal endocycle
progression. Similarly, in a megakaryocytic cell line,
differentiation is correlated with a downregulation of p27
(Fredersdorf et al., 1997). We propose that the downregulation
of Dacapo is a reasonable strategy to bypass the G1/S transition
and to enter endocycling when mitosis is not completed,
however, how these endocycling cells escape possible
centrosome amplification and apoptosis that could be
consequences of the lack of Dacapo/p21-activity is not clear.
This diversity in the processes, that allow cells to exit from
mitotic cell cycle, is generating or representing regulatory
multiplicity that might be reflected in the ways eukaryotic cells
acquire tumor formation capacity.
Notch as a tumor suppressor
Recent findings by Rangarajan et al. and Nicolas et al.,
(Nicolas et al., 2003; Rangarajan et al., 2001) have shown that
Notch acts as a tumor suppressor in mouse skin epithelium.
Ablation of Notch results in epidermal and corneal hyperplasia
followed by the development of skin tumors and facilitated
chemical-induced skin carcinogenesis. In these cell types
Notch1 deficiency results in increased and sustained expression
of Gli2 and derepression of beta-catenin. Therefore the authors
have suggested, that in mouse skin epithelium Notch pathway
represses the activity of Hedgehog- and Wingless-signaling
pathways. It remains to be seen whether Notch activity
in Drosophila follicle cells impinges directly on the
transcriptional regulation of string, dacapo and fzr or whether
Notch acts through another signaling pathway.
Our studies of follicle cell cycle programs in the ovary are
important because they provide a comparison with other cell
cycle programs in Drosophila development. Furthermore, the
transition from mitotic cycles to endocycles is a universal
phenomena; understanding how molecular events bring about
this transition in follicle cells will shed light on such transitions
in general.
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